Close Lucintel Chat
Didn't Find What You're Looking for?
Call us at +1972 636 5056 or write at helpdesk@Lucintel.com
Ask an Expert Provide Custom Requirements Download Sample Report Search Available Reports
  • helpdesk@Lucintel.com
  • |
  • Call Lucintel +1 972 636 5056
  • |
  • Login
  • |
  • Register
  • |
  • Search
  • |
'
...

The Impact of COVID-19 is included in Narcolepsy Drug Market Report. Buy it today to get an advantage.

Request the impact of COVID-19 on your product or industry


Narcolepsy Drug Trends and Forecast

The future of the global narcolepsy drug market looks promising with opportunities in the central nervous system stimulants, tricyclic antidepressants, sodium oxybate, and selective serotonin reuptake inhibitor markets. The global narcolepsy drug market is expected to grow with a CAGR of 9.4% from 2024 to 2030. The major drivers for this market are increasing awareness towards narcolepsy and its symptoms among healthcare professionals and rising global prevalence of narcolepsy owing to increasing stress, peer pressure, and social & economic hardships.
Narcolepsy Drug Trends and Forecast

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Narcolepsy Drug by Segment

Narcolepsy Drug by Segment

The study includes a forecast for the global narcolepsy drug by disease type, therapeutics type, and region.

Narcolepsy Drug Market by Disease Type [Shipment Analysis by Value from 2018 to 2030]:


• Daytime Extreme Sleepiness
• Cataplexia
• Others

• Central Nervous System Stimulants
• Tricyclic Antidepressants
• Sodium Oxybate
• Selective Serotonin Reuptake Inhibitor
• Others

Narcolepsy Drug Market by Region [Shipment Analysis by Value from 2018 to 2030]:


• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Narcolepsy Drug Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies narcolepsy drug companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the narcolepsy drug companies profiled in this report include-
• Arena Pharmaceuticals
• Bioprojet Company
• Graymark Healthcare
• Hikma Pharmaceuticals
• Jazz Pharmaceuticals
• Ligand Pharmaceuticals Incorporated
• Shionogi

Narcolepsy Drug Market Insights

Lucintel forecasts that daytime extreme sleepiness will remain the larger segment over the forecast period due to development of drugs for treating narcolepsy.
Within this market, sodium oxybate will remain the largest segment due to extensive utilization in the narcolepsy treatment.
North America is expected to witness highest growth over the forecast period due to growing prevalence of unhealthy lifestyles along with increase in R&D activities in the region.

Features of the Global Narcolepsy Drug Market

Market Size Estimates: Narcolepsy drug market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Narcolepsy drug market size by disease type, therapeutics type, and region in terms of value ($B).
Regional Analysis: Narcolepsy drug market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different disease types, therapeutics types, and regions for the narcolepsy drug market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the narcolepsy drug market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.

FAQ

Q1. What is the growth forecast for narcolepsy drug market?
Answer: The global narcolepsy drug market is expected to grow with a CAGR of 9.4% from 2024 to 2030.
Q2. What are the major drivers influencing the growth of the narcolepsy drug market?
Answer: The major drivers for this market are increasing awareness towards narcolepsy and its symptoms among healthcare professionals and rising global prevalence of narcolepsy owing to increasing stress, peer pressure, and social & economic hardships.
Q3. What are the major segments for narcolepsy drug market?
Answer: The future of the narcolepsy drug market looks promising with opportunities in the central nervous system stimulants, tricyclic antidepressants, sodium oxybate, and selective serotonin reuptake inhibitor markets.
Q4. Who are the key narcolepsy drug market companies?
Answer: Some of the key narcolepsy drug companies are as follows:
• Arena Pharmaceuticals
• Bioprojet Company
• Graymark Healthcare
• Hikma Pharmaceuticals
• Jazz Pharmaceuticals
• Ligand Pharmaceuticals Incorporated
• Shionogi
Q5. Which narcolepsy drug market segment will be the largest in future?
Answer: Lucintel forecasts that daytime extreme sleepiness will remain the larger segment over the forecast period due to development of drugs for treating narcolepsy.
Q6. In narcolepsy drug market, which region is expected to be the largest in next 5 years?
Answer: North America is expected to witness highest growth over the forecast period due to growing prevalence of unhealthy lifestyles along with increase in R&D activities in the region.
Q.7. Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

Q.1. What are some of the most promising, high-growth opportunities for the narcolepsy drug market by disease type (daytime extreme sleepiness, cataplexia, and others), therapeutics type (central nervous system stimulants, tricyclic antidepressants, sodium oxybate, selective serotonin reuptake inhibitor, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

For any questions related to Narcolepsy Drug Market, Narcolepsy Drug Market Size, Narcolepsy Drug Market Growth, Narcolepsy Drug Market Analysis, Narcolepsy Drug Market Report, Narcolepsy Drug Market Share, Narcolepsy Drug Market Trends, Narcolepsy Drug Market Forecast, Narcolepsy Drug Companies, write Lucintel analyst at email: helpdesk@lucintel.com. We will be glad to get back to you soon.
Table of Contents

1. Executive Summary
2. Global Narcolepsy Drug Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges 
3. Market Trends and Forecast Analysis from 2018 to 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Narcolepsy Drug Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Narcolepsy Drug Market by Disease Type
3.3.1: Daytime Extreme Sleepiness
3.3.2: Cataplexia
3.3.3: Others
3.4: Global Narcolepsy Drug Market by Therapeutics Type
3.4.1: Central Nervous System Stimulants
3.4.2: Tricyclic Antidepressants
3.4.3: Sodium Oxybate
3.4.4: Selective Serotonin Reuptake Inhibitor
3.4.5: Others
4. Market Trends and Forecast Analysis by Region from 2018 to 2030
4.1: Global Narcolepsy Drug Market by Region
4.2: North American Narcolepsy Drug Market
4.2.1: North American Narcolepsy Drug Market by Disease Type: Daytime Extreme Sleepiness, Cataplexia, and Others
4.2.2: North American Narcolepsy Drug Market by Therapeutics Type: Central Nervous System Stimulants, Tricyclic Antidepressants, Sodium Oxybate, Selective Serotonin Reuptake Inhibitor, and Others
4.3: European Narcolepsy Drug Market
4.3.1: European Narcolepsy Drug Market by Disease Type: Daytime Extreme Sleepiness, Cataplexia, and Others
4.3.2: European Narcolepsy Drug Market by Therapeutics Type: Central Nervous System Stimulants, Tricyclic Antidepressants, Sodium Oxybate, Selective Serotonin Reuptake Inhibitor, and Others
4.4: APAC Narcolepsy Drug Market
4.4.1: APAC Narcolepsy Drug Market by Disease Type: Daytime Extreme Sleepiness, Cataplexia, and Others
4.4.2: APAC Narcolepsy Drug Market by Therapeutics Type: Central Nervous System Stimulants, Tricyclic Antidepressants, Sodium Oxybate, Selective Serotonin Reuptake Inhibitor, and Others
4.5: ROW Narcolepsy Drug Market
4.5.1: ROW Narcolepsy Drug Market by Disease Type: Daytime Extreme Sleepiness, Cataplexia, and Others
4.5.2: ROW Narcolepsy Drug Market by Therapeutics Type: Central Nervous System Stimulants, Tricyclic Antidepressants, Sodium Oxybate, Selective Serotonin Reuptake Inhibitor, and Others
5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Narcolepsy Drug Market by Disease Type
6.1.2: Growth Opportunities for the Global Narcolepsy Drug Market by Therapeutics Type
6.1.3: Growth Opportunities for the Global Narcolepsy Drug Market by Region
6.2: Emerging Trends in the Global Narcolepsy Drug Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Narcolepsy Drug Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Narcolepsy Drug Market
6.3.4: Certification and Licensing
7. Company Profiles of Leading Players
7.1: Arena Pharmaceuticals
7.2: Bioprojet Company
7.3: Graymark Healthcare
7.4: Hikma Pharmaceuticals
7.5: Jazz Pharmaceuticals
7.6: Ligand Pharmaceuticals Incorporated
7.7: Shionogi
.

Buy full report or by chapter as follows

Price by License Type:
[-] Hide Chapter Details
[Chapter Number] [Chapter Name] [Chapter Number Of Pages] [Chapter Price]
Title/Chapter Name Pages Price
Full Report: Narcolepsy Drug Market Report: Trends, Forecast and Competitive Analysis to 2030 Full Report $ 4,850
A 150 Page Report
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
  • In-depth interviews of the major players in this market
  • Detailed secondary research from competitors’ financial statements and published data 
  • Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
  • A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
 
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.